Hotline
Morpholine / Related Application Product
Home  Morpholine  Related Application Product  Ciprofibrate

Ciprofibrate

Date：2021-09-18      Categories：Related Application Product

  Post Date: Sep 18,2021
  Expiry Date: Sep 18,2022
  Detailed Description: Cas No. :52214-84-3

Product name: Ciprofibrate
Alias: 2-[4-(2,2-Dichlorocyclopropyl)phenoxy]-2-methylpropanoic acid
Structural formula:

Molecular formula: C13H14Cl2O3
Molecular weight: 289.16
CAS No.: 52214-84-3
EINECS No.: 257-744-6
Density: 1.37g/cm3
Boiling Point: 424.9°C at 760 mmHg
Flash point: 210.7°C
From hexane to get light cream solid,Melting point114-116°C.
Vapor pressure: 5.63E-08mmHg at 25°C
Purity: 98% HPLC
Usage: Lipid-lowering drugs, as well as anti-platelet aggregation and the role of soluble fibrin. Little effect in the diet, especially high blood cholesterol or are still in danger of complications, and other drugs alone or in combination treatment of adults with high cholesterol and high endogenous hypertriglyceridemia.

  CAS Registry Number:

52214-84-3
  Synonyms: ;2-(p-(2,2-Dichlorocyclopropyl)phenoxy)-2-methylpropionic acid;BRN 1984981;CCRIS 173;Ciprofibrato;Ciprofibrato [INN-Spanish];Ciprofibratum;Ciprofibratum [INN-Latin];UNII-F8252JGO9S;WIN 35833;2-(4-(2,2-Dichlorocyclopropyl)phenoxy)2-methylpropanoic acid;Propanoic acid, 2-(4-(2,2-dichlorocyclopropyl)phenoxy)-2-methyl-;
  Molecular Formula: C13H14Cl2O3
  Molecular Weight: 289.1545
  Molecular Structure: 52214-84-3 ciprofibrate
  Hazard Symbols:  T:Toxic;
  Risk Codes: R45:;
  Safety Description: S53:;
S22:;
S36/37/39:;
S45:;

Prev：
Next：

Related